Contrast-Enhanced Ultrasound Improves the Pathological Outcomes of US-Guided Core Needle Biopsy That Targets the Viable Area of Anterior Mediastinal Masses
Table 1
Baseline characteristics, prebiopsy ultrasonographic features, and outcomes of 92 patients with AMMs who underwent initial US-CNB with prebiopsy conventional US or CEUS evaluation.
US
CEUS
value
Age (years), mean ± SD
0.763
Gender, male/female
50/25
14/3
0.207
Cancer history yes/no
3/75
2/17
0.205
Location of AMMs (both/left/right)
8/40/27
0/10/7
0.408
Size of AMMs (mm), mean ± SD
0.721
CDFI category (marked/not marked)
29/46
3/14
0.074
Marginal blood flow signals (presence/absence)
47/28
15/2
0.043
Necrosis (presence/absence)
8/67
5/12
0.046
Punctures of core needle (mean ± SD)
0.333
Repeated US-guided CNB (no/yes)
17/58
0/17
0.031
Conclusive histological diagnoses (no/yes)
20/55
1/16
0.067
Cellularity (mean ± SD)
0.001
Lung tissue in the sample (presence/absence)
6/69
0/17
0.144
Duration between initial CNB and treatment decision (days mean ± SD)
